LIXT: Lixte Biotechnology Holdings, Inc. Stock

by  •  • Comments Off on LIXT: Lixte Biotechnology Holdings, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 5.22
Enterprise Value ($M) 5.30
Book Value ($M) 3.13
Book Value / Share 1.39
Price / Book 1.67
NCAV ($M) 3.13
NCAV / Share 1.39
Price / NCAV 1.67

Profitability (mra)
Return on Invested Capital (ROIC) -1.50
Return on Assets (ROA) -1.52
Return on Equity (ROE) -1.74

Liquidity (mrq)
Quick Ratio 7.75
Current Ratio 7.75

Balance Sheet (mrq) ($M)
Current Assets 3.59
Assets 3.59
Liabilities 0.46
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -5.09
Net Income -5.09
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -4.29
Cash from Investing 0.00
Cash from Financing 3.14

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 853 9,057 9.42
2024-07-25 3 521 0.58
2024-07-24 378 2,340 16.15
2024-07-23 587 9,937 5.91
2024-07-22 22 612 3.59

(click for more detail)

Similar Companies
LFVN – LifeVantage Corporation LGVN – Longeveron Inc.
LIPO – Lipella Pharmaceuticals Inc. LPCN – Lipocine Inc.
LPTX – Leap Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io